Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs midazolam sedation in mechanically ventilated AECOPD patients
ChiCTR2100047775Phase 4Not yet recruiting
- Sponsor
- Cangzhou Central Hospital
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam and midazolam in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Cangzhou Central Hospital. Primary endpoints: Sedation score and Confusion assessment sheet for Intensive Care Unit patients. Planned start Jan 2020; status: not yet recruiting.
02
Drugs
remimazolammidazolam
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR2100047775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100047775.